In a move to demystify the conversation around obesity and weight management medications, Oprah Winfrey has taken to the airwaves…
The recent expansion of Novo Nordisk A/S’s NVO Wegovy’s (semaglutide) FDA approval has sparked a debate over insurance coverage for the drug. However,…
As the weight-loss frenzy fueled by social media endorsements and Hollywood glamour continues to surge, the battle against counterfeit medications has…
In response to growing reports of patient harm caused by counterfeit versions of its popular diabetes drug, Ozempic (semaglutide), Novo Nordisk…
Novo Nordisk A/S NVO’s Wegovy garnered the Food and Drug Administration’s approval for expanded use Friday, marking what the drugmaker…
Novo Nordisk A/S’s NVO head of development, Martin Holst Lange, expressed strong confidence in the drugmaker’s ability to launch the pill version…
A new study found that the interaction between cannabis and popular weight-loss drugs such as Ozempic and Wegovy can have…
Thursday, Novo Nordisk A/S NVO is holding its Capital Markets Day. Its executive management and other members of senior management will provide…
The weekly injection of semaglutide has proven to be both safe and effective, reducing liver fat in individuals with HIV…
Editor’s note: This story has been updated to reflect a new press release issued by Novo Nordisk that clarifies details…